PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
450.49%
Positive net income growth while Healthcare median is negative at -0.32%. Peter Lynch would view it as a strong advantage vs. struggling peers.
12.61%
D&A growth of 12.61% while Healthcare median is zero at 0.00%. Walter Schloss would question intangible or new expansions driving that cost difference.
-2541.17%
Deferred tax shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see potential advantage if actual tax outflows do not spike.
423.14%
SBC growth of 423.14% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or staff additions causing more equity grants.
329.61%
Working capital of 329.61% while Healthcare median is zero at 0.00%. Walter Schloss would check if expansions or cost inefficiencies cause that difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
109.70%
Under 50% of Healthcare median of 1.70% if negative or well above if positive. Jim Chanos would flag potential major accounting illusions or revaluations overshadowing underlying performance.
437.30%
CFO growth of 437.30% while Healthcare median is zero at 0.00%. Walter Schloss would see a small edge that may compound with consistent execution.
-407.48%
CapEx declines yoy while Healthcare median is 0.00%. Seth Klarman would note a short-term FCF advantage if revenue is stable.
No Data
No Data available this quarter, please select a different quarter.
-1225.05%
Investment purchases shrink yoy while Healthcare median is 0.00%. Seth Klarman would see a short-term cash advantage if no high-return opportunities are missed.
No Data
No Data available this quarter, please select a different quarter.
-85.11%
We reduce “other investing” yoy while Healthcare median is 0.00%. Seth Klarman would see a potential advantage in preserving cash if top-line growth is not harmed.
-692.42%
Reduced investing yoy while Healthcare median is 0.00%. Seth Klarman sees potential advantage in near-term liquidity if revenue remains stable.
-7.81%
Debt repayment yoy declines while Healthcare median is 0.00%. Seth Klarman fears increased leverage if expansions do not yield quick returns.
54.21%
Issuance growth of 54.21% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or acquisitions financed by new shares.
No Data
No Data available this quarter, please select a different quarter.